These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 8348706

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity.
    Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, Bellastella A, Santeusanio F, De Bellis A.
    Fertil Steril; 2002 Aug; 78(2):270-9. PubMed ID: 12137862
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
    de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A.
    Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
    Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F.
    Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. High frequency of endocrine autoimmunity in patients with sarcoidosis.
    Papadopoulos KI, Hörnblad Y, Liljebladh H, Hallengren B.
    Eur J Endocrinol; 1996 Mar; 134(3):331-6. PubMed ID: 8616531
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Update on autoimmune polyendocrine syndromes (APS).
    Betterle C, Zanchetta R.
    Acta Biomed; 2003 Apr; 74(1):9-33. PubMed ID: 12817789
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Addison's disease: principal clinical associations and description of natural history of the disease].
    Betterle C, Scalici C, Pedini B, Mantero F.
    Ann Ital Med Int; 1989 Apr; 4(3):195-206. PubMed ID: 2702031
    [Abstract] [Full Text] [Related]

  • 38. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity.
    Weetman AP.
    Baillieres Clin Endocrinol Metab; 1995 Jan; 9(1):157-74. PubMed ID: 7726795
    [Abstract] [Full Text] [Related]

  • 39. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure.
    Ahonen P, Miettinen A, Perheentupa J.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):494-500. PubMed ID: 3818889
    [Abstract] [Full Text] [Related]

  • 40. [Polyglandular type I autoimmune syndrome].
    Schmitt K, Tulzer G, Tulzer W.
    Wien Klin Wochenschr; 1992 Mar; 104(11):325-7. PubMed ID: 1621394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.